Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
186.80    0.20 (0.11%)
Bid:
186.40
Ask:
186.60
Spread: 0.20 (0.107%)
Market Cap: £1.88b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Result of AGM

31 Jul 2017 13:02

RNS Number : 6041M
B&M European Value Retail S.A.
31 July 2017
 

 

 

31 July 2017

B&M European Value Retail S.A.

 

 

AGM Voting Results

 

 

All resolutions proposed at the Annual General Meeting of the Company held on 28 July 2017 were passed on a poll by shareholders. The results of the poll were as follows.

 

VOTES

 FOR

%

VOTES

AGAINST

%

VOTES

TOTAL

% of ISC

VOTED

VOTES WITHHELD

1

To receive the Directors Report on the Annual Accounts of the Company for the year ended March 2017

 

776,010,272

100

0

0

776,010,272

77.60

826,564

2

To receive the consolidated and unconsolidated Financial Statements and Annual Accounts for the financial year ended March 2017 and the Auditor's Reports thereon

 

775,576,207

99.95

400,000

0.05

775,976,207

77.60

860,629

3

To approve the consolidated Financial Statements and Annual Accounts of the Company for the year ended 25 March 2017

776,010,272

100

0

0

776,010,272

77.60

826,564

4

To approve the unconsolidated Financial Statements and Annual Accounts of the Company for the year ended 31 March 2017

 

776,010,272

100

0

0

776,010,272

77.60

826,564

5

To approve the result of the Company for the year ended 31 March 2017 and allocation

 

776,010,272

100

0

0

776,010,272

77.60

826,564

6

To approve the total dividend of the Company for the year ended 31 March 2017

 

776,010,272

100

0

0

776,010,272

77.60

826,564

7

 

To receive and approve the annual report on the Directors' Remuneration for the year ended March 2017

 

752,544,703

96.98

23,465,569

3.02

776,010,272

77.60

826,564

8

To discharge the Directors for the year ended 31 March 2017

 

776,007,272

100

0

0

776,007,272

77.60

829,564

9

To re-elect Sir Terry Leahy as a Director

 

744,916,893

95.99

31,093,379

4.01

776,010,272

77.60

826,564

10

To re-elect Simon Arora as a Director

 

769,104,720

99.11

6,905,552

0.89

776,010,272

77.60

826,564

11

To re-elect David Novak as a Director

 

733,370,477

95.34

35,856,281

4.66

769,226,758

76.92

7,610,078

12

 

To re-elect Paul McDonald as a Director

770,547,779

99.30

5,462,493

0.70

776,010,272

77.60

826,564

13

To re-elect Thomas Hübner as a Director

 

767,830,946

98.95

8,179,326

1.05

776,010,272

77.60

826,564

14

To re-elect Kathleen Guion as a Director

 

774,771,295

99.84

1,238,977

0.16

776,010,272

77.60

826,564

15

To re-elect Ron McMillan as a Director

765,990,626

98.71

10,019,646

1.29

776,010,272

77.60

826,564

16

To re-elect Harry Brouwer as a Director

 

767,830,946

98.95

8,179,326

1.05

776,010,272

77.60

826,564

17

To discharge the Independent Auditor for the year ended 31 March 2016

 

776,010,272

100

0

0

776,010,272

77.60

826,564

18

To re-appoint KPMG Luxembourg Société Coopérative as Independent Auditor of the Company

 

774,216,575

99.99

86,543

0.01

774,303,118

77.43

2,533,718

19

 

 

 

To authorise the Directors to determine the Independent Auditor's remuneration

774,798,655

99.84

1,211,617

0.16

776,010,272

77.60

826,564

20

To authorise the Company to make market purchases of its ordinary shares

 

772,751,513

99.74

2,047,142

0.26

774,798,655

77.48

2,038,181

21

To confirm the Board of Directors have full power to issue ordinary shares on a non-pre-emptive basis for cash representing 5% of the issued share capital of the Company generally, as provided by the Articles of Association and to acknowledge the Directors' intention to comply with the Statement of Principles on Dis-applying Pre-Emption Rights to the extent practical for a Luxembourg company

 

775,850,000

99.98

160,272

0.02

776,010,272

77.60

826,564

22

To confirm the Board of Directors have full power, in addition to any authority granted under resolution 21, to issue ordinary shares on a non-pre-emptive basis, for cash representing a further 5% of the issued share capital of the Company for the purposes of financing an acquisition or a capital investment (or refinancing such a transaction) as defined in the Statement of Principles on Dis-Applying Pre-Emption Rights, as provided by the Articles of Association

732,418,368

94.38

43,591,904

5.62

776,010,272

77.60

826,564

 

 

 

The results of the poll will also be posted on the Company's website at www.bandmretail.com/investors/agm.aspx 

 

Please note that a vote withheld is not a vote in law and is not counted in the calculation of votes for and against a resolution.

 

The total number of shares in issue of the Company at the date of the AGM was 1,000,000,000 ordinary shares.  

Enquiries

 

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400

Simon Arora, Chief Executive Officer

Paul McDonald, Chief Financial Officer

 

Investor.relations@bandmretail.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGLFLFXDDFBBBF
Date   Source Headline
18th Jun 202610:00 amRNSBoard Retirement
18th Jun 202610:00 amRNSPublication of Annual Report and Notice of AGM
16th Jun 202612:00 pmRNSDirector/PDMR Shareholding
11th Jun 20261:00 pmRNSTiming of Q1 FY27 Trading Statement
3rd Jun 20267:00 amRNSFY26 Preliminary Results
10th Apr 20269:00 amRNSDirectorate Changes and Leadership Appointments
26th Mar 20264:45 pmRNSMajor Holding(s) in Company - TR1
24th Mar 20264:30 pmRNSMajor Holding(s) in Company - TR1
17th Mar 20265:31 pmRNSMajor Holding(s) in Company - TR1
17th Mar 20265:30 pmRNSMajor Holding(s) in Company - TR1
9th Mar 20263:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20268:00 amRNSAdmission of B&M Jersey Shares
2nd Mar 20268:00 amRNSReadmission - B&M European Value Retail S.A.
27th Feb 20264:48 pmRNSMigration Completion
25th Feb 202611:00 amRNSPublication of a Prospectus - Migration
24th Feb 20261:00 pmRNSDirector/PDMR Shareholding
22nd Jan 20262:00 pmRNSUpdate statement on 2025 AGM voting results
22nd Jan 20267:00 amRNSQ3 FY26 Trading Statement
15th Jan 20269:00 amRNSBlock listing Interim Review
23rd Dec 20252:00 pmRNSTiming of Q3 FY26 Trading Statement
23rd Dec 20252:00 pmRNSTiming of Q3 FY26 Trading Statement
19th Dec 20259:00 amRNSMajor Holding in Company - TR1
19th Dec 20259:00 amRNSMajor Holding in Company - TR1
4th Dec 202510:00 amRNSMajor Holding in Company - TR1
28th Nov 202511:00 amRNSMajor Holding in Company - TR1
26th Nov 20259:30 amRNSMajor Holding in Company TR1
24th Nov 20252:30 pmRNSMajor Holding in Company- TR1
20th Nov 20254:00 pmRNSCEO Purchase of shares
20th Nov 202511:00 amRNSCEO Purchase of Shares
19th Nov 20259:01 amRNSCEO Purchase of Shares
19th Nov 20259:00 amRNSMajor Holding in Company TR1
18th Nov 202511:00 amRNSCEO Purchase of Shares
18th Nov 202510:58 amRNSMajor Holding in Company- TR1
14th Nov 20253:30 pmRNSMajor Holding in Company TR1
13th Nov 20257:00 amRNSFY26 Interim Results
4th Nov 20256:05 pmRNSMajor Holding in Company TR1
4th Nov 20256:00 pmRNSMajor Holding in Company TR1
30th Oct 20259:00 amRNSMajor Holding in Company TR1
28th Oct 20254:00 pmRNSMajor Holding in Company TR1
27th Oct 20251:01 pmRNSMajor Holding in Company TR1
27th Oct 20251:00 pmRNSMajor Holding in Company TR1
20th Oct 20257:00 amRNSUpdate on FY26 Guidance and Directorate Change
13th Oct 20253:30 pmRNSInformation to shareholders: statutory migration
7th Oct 20257:00 amRNSFY26 H1 Trading and Operational Update
22nd Sep 202511:30 amRNSCEO Purchase of Shares
18th Sep 20256:00 pmRNSDirector/PDMR Shareholding
15th Sep 20254:34 pmRNSCEO Purchase of Shares
11th Sep 202511:00 amRNSCEO Purchase of Shares
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20254:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.